type I citrullinemia | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

55,072 results for “type I citrullinemia”

NIH Grant Funds Gene-Editing Research for Rare Metabolic Disorders

Giant Biogene Receives NMPA Approval for First Recombinant Type I Collagen Injectable Device

ARS Pharma's Neffy Aims to Expand Pediatric Access for Type 1 Allergic Reactions

MEDIPAL and JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome Type B

Gan & Lee's Once-Weekly Insulin GZR4 Shows Promising Phase I Results in Type 2 Diabetes

GC Biopharma and Novel Pharma Initiate Phase I Trial of GC1130A for Sanfilippo Syndrome Type A

Leyden Labs Advances Intranasal RIG-I Agonist RIG-101 to Rhinovirus Challenge Trial After Phase I Safety and Biomarker Success

Embecta's Tubeless Insulin Patch Pump Receives FDA Clearance for Diabetes Management

FDA Lifts Clinical Hold on Biomea Fusion's Diabetes Trials of BMF-219

Avistone's ANS014004, a Novel c-Met Inhibitor, Advances in Phase I Trials for Solid Tumors

Page 1 of 1032